CHE logo

Chemed Corp (CHE)

$419.65

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on CHE

Market cap

$5.57B

EPS

18.32

P/E ratio

22.9

Price to sales

2.21

Dividend yield

0.572%

Beta

0.541683

Price on CHE

Previous close

$421.43

Today's open

$424.49

Day's range

$412.75 - $424.49

52 week range

$365.21 - $583.96

Profile about CHE

CEO

Kevin J. McNamara

Employees

15811

Headquarters

Cincinnati, OH

Exchange

New York Stock Exchange

Shares outstanding

13274104

Issue type

Common Stock

CHE industries and sectors

Healthcare

Healthcare Providers & Services

News on CHE

Chemed Corporation to Present at the 2026 RBC Global Healthcare Conference

CINCINNATI, May 13, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 20, 2026, at approximately 8:30 a.m. (ET) at The InterContinental New York Barclay Hotel in New York City.

news source

GlobeNewsWire • 10 hours ago

news preview

Chemtrade Logistics Income Fund (CHE.UN:CA) Q1 2026 Earnings Call Prepared Remarks Transcript

Chemtrade Logistics Income Fund (CHE.UN:CA) Q1 2026 Earnings Call Prepared Remarks Transcript

news source

Seeking Alpha • 2 hours ago

news preview

Chemed Corporation (CHE) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Chemed Corporation (CHE) Presents at Bank of America Global Healthcare Conference 2026 Transcript

news source

Seeking Alpha • a day ago

news preview

Chemtrade Logistics Income Fund (CHE.UN:CA) Q1 2026 Earnings Call Transcript

Chemtrade Logistics Income Fund (CHE.UN:CA) Q1 2026 Earnings Call Transcript

news source

Seeking Alpha • May 12, 2026

news preview

Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2026

CINCINNATI, May 05, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities 2026 Health Care Conference on Tuesday, May 12, 2026, at 3:00 PM (PDT) at the Encore at the Wynn Las Vegas. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations).

news source

GlobeNewsWire • May 5, 2026

news preview

CHE Stock Up Following Q1 Earnings & Revenue Beat, Margins Down

Chemed stock jumps after Q1 earnings and revenues beat estimates despite margin contraction and mixed segment performance across VITAS and Roto-Rooter.

news source

Zacks Investment Research • Apr 27, 2026

news preview

Chemed Corporation (CHE) Q1 2026 Earnings Call Transcript

Chemed Corporation (CHE) Q1 2026 Earnings Call Transcript

news source

Seeking Alpha • Apr 24, 2026

news preview

Chemed Reports First-Quarter 2026 Results

Full-Year Guidance Increased Due To: Strong VITAS Performance Re-purchase of 500,000 Shares in the Quarter Two Roto-Rooter Franchises Purchased for $20.6 Million CINCINNATI, April 23, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2026, versus the comparable prior-year period. Results for Quarter Ended March 31, 2026 Consolidated operating results: Revenue increased 1.6% to $657.5 million GAAP Diluted Earnings-per-Share (EPS) of $4.84, a decrease of 0.4% Adjusted Diluted EPS of $5.65, an increase of 0.4% VITAS segment operating results: Net Patient Revenue of $420.0 million, an increase of 3.1% Average Daily Census (ADC) of 22,723, an increase of 2.2% Admissions of 19,394, an increase of 6.9% Net Income, excluding certain discrete items, of $52.2 million, an increase of 4.4% Adjusted EBITDA, excluding Medicare Cap, of $70.8 million, an increase of 0.6% Adjusted EBITDA margin, excluding Medicare Cap, of 16.8%, a decrease of 41-basis points Roto-Rooter segment operating results: Revenue of $237.5 million, a decrease of 0.9% Net Income, excluding certain discrete items, of $37.7 million, a decrease of 9.7% Adjusted EBITDA of $53.5 million, a decline of 9.6% Adjusted EBITDA margin of 22.5%, a decline of 218-basis points VITAS VITAS net revenue was $420.0 million in the first quarter of 2026, which is an increase of 3.1% when compared to the prior-year period.

news source

GlobeNewsWire • Apr 23, 2026

news preview

Chemed (CHE) Beats Q1 Earnings and Revenue Estimates

Chemed (CHE) came out with quarterly earnings of $5.65 per share, beating the Zacks Consensus Estimate of $5.17 per share. This compares to earnings of $5.63 per share a year ago.

news source

Zacks Investment Research • Apr 23, 2026

news preview

This Newsletter Has a Multidecade Market-Beating Record. How It Finds Winning Stocks—and Dodges Losers.

Investment Quality Trends' yield-focused model portfolios have beaten the broad stock market since 1986.

news source

Barrons • Apr 20, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Chemed Corp

Open an M1 investment account to buy and sell Chemed Corp commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in CHE on M1